The promise of precision medicine is to deliver highly targeted treatment to every single diseased cell. The current one-size-fits-all approach of medical treatments isn’t working for many patients who need help. To move precision medicine forward, researchers and clinicians need to look at the origins of disease — the single cell — in meaningful new ways.
See What You’re Missing
The Precision Genomics Platform™
Tapestri is the industry’s first targeted single-cell DNA sequencing platform, enabling precise detection of heterogeneity in disease progression and treatment response. The platform includes an instrument, consumables, and analysis software, which integrate seamlessly with existing NGS workflows. With Tapestri, researchers have a highly sensitive, targeted, and customizable solution to move precision medicine forward.
Mission Bio’s Proprietary Single-Cell Genomics ...
Mission Bio Raises $30M to Scale the First-ever...
Application / Technical Notes
Solid Tumor Application Note
Precision Sequencing with Single-Cell Genomics: Resolving Heterogeneity...